α1-antitrypsin precursor in gastric juice is a novel biomarker for gastric cancer and ulcer

Clinical Cancer Research

Volumn 13, Issue 3, 2007, Pages 876-883

  Hsu, Ping I ^a   Chen, Chung Hsuan ^b   Hsieh, Chieu Shia ^a   Chang, Wei Chao ^b   Lai, Kwok Hung ^a   Lo, Gin Ho ^a   Hsu, Ping Ning ^c   Tsay, Feng Woei ^a   Chen, Yu Shan ^a   Hsiao, Michael ^b   Chen, Hui Chun ^d   Lu, Pei Jung ^e,f  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^f KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; PEPTIDE; PROTEIN PRECURSOR; TRYPSIN; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; DUODENUM ULCER; HUMAN; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; STOMACH CANCER; STOMACH JUICE; STOMACH ULCER; TWO DIMENSIONAL GEL ELECTROPHORESIS; ADULT; BIOSYNTHESIS; CHEMISTRY; FEMALE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PH; RISK; STOMACH; STOMACH TUMOR; ULCER;

ADULT; ALPHA 1-ANTITRYPSIN; DUODENAL ULCER; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GASTRIC JUICE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MASS SPECTROMETRY; MIDDLE AGED; ODDS RATIO; PEPTIDES; PROTEIN PRECURSORS; PROTEOMICS; STOMACH; STOMACH NEOPLASMS; TRYPSIN; TUMOR MARKERS, BIOLOGICAL; ULCER;

EID: 33847406161     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-1404     Document Type: Article

References (31)

1. Freeman HJ, Kim YS. Digestion and absorption of protein. Annu Rev Med 1978;29:99-116.
2. Duraker N, Naci Celik A, Gencler N. The prognostic significance of gastric juice CA 19-9 and CEA levels in gastric carcinoma patients. Eur J Surg Oncol 2002;28:844-9.
3. Kasirga E, Coker I, Aydogdu S, et al. Increased gastric juice leukotriene B4, C4, and E4 concentrations in children with Helicobacter pylori colonization. Turk J Pediatr 1999;41:335-9.
4. Marcinkiewicz M, Peura DA, Sarosiek J. The relationship between the content of aggressive and protective components in gastric juice and endoscopic findings after naproxen sodium and acetaminophen administration. Am J Gastroenterol 1996;91:360-5.
5. Muretto P, Graziano F, Staccioli MP, et al. An endogastric capsule for measuring tumor markers in gastric juice: an evaluation of the safety and efficacy of a new diagnostic tool. Ann Oncol 2003;14:105-9.
6. Perez-Trallero E, Montes M, Alcorta M, et al. Non-endoscopic method to obtain Helicobacter pylori for culture. Lancet 1995;345:622-3.
7. Wang SW, Yu FJ, Lo YC, et al. The clinical utility of string-PCR test in diagnosing Helicobacter pylori infection. Hepatogastroenterology 2003;50:1208-13.
8. Wu MS, Shun CT, Wang HP, et al. Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology 1997;112:1457-65.
9. Moss SF. Cellular markers in the gastric precancerous process. Aliment Pharmacol Ther 1998;12:91-109.
10. Hsu PI, Lai KH, Chien EJ, et al. Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis. Anticancer Res 2000;20:1221-8.
11. Xiao Z, Prieto D, Conrads TP, et al. Proteomic patterns: their potential for disease diagnosis. Mol Cell Endocr 2005;230:95-106.
12. Chen HC, Chu RY, Hsu PN, et al. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Let 2003;201:97-106.
13. Ascano JJ, Frierson H, Moskaluk CA, et al. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Mol Pathology 2001;14:942-9.
14. Ohene-Abuakwa Y, Noda M, Perenyi M, et al. Expression of the E-cadherin/catenin (α-, β, and γ-) complex correlates with the macroscopic appearance of early gastric cancer. J Pathol 2000;192:433-9.
15. Hsu PI, Lai KH, Lo GH, et al. Risk factors of ulcer development in patients with non-ulcer dyspepsia: a prospective 2-year follow-up study of 209 patients. Gut 2002;51:15-20.
16. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at histoclinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
17. Murakami T. Pathomorphological diagnosis: definition and gross classification of early gastric cancer. Gann Monogr Cancer Res 1971;11:53-5.
18. Hsu PI, Lai KH, Tseng HH, et al. Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia. J Clin Gastroenterol 1997;25:587-91.
19. Chen A, Li CN, Hsu PI, et al. Risks of interleukin-1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer. Aliment Pharmacol Ther 2004;20:203-11.
20. Dixon MF, Genta RM, Yardly JH, et al. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996;20:1161-81.
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
22. Puchades M, Hansson SF, Nilsson CL, et al. Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Mol Brain Res 2003;118:140-6.
23. Ha GH, Lee SU, Kang DG, et al. Proteomic analysis of human stomach tissue: separation of soluble proteins by two-dimensional polyacrylamide gel electrophoresis and identification by mass spectrometry. Electrophoresis 2002;23:2513-24.
24. Katayama H, Nagasu T, Oda Y. Optimization of in-gel protein digestion system in combination with thin-gel separation and negative staining in 96-well plate format. Rapid Commun Mass Spectrom 2003;17:1071-8.
25. Patchett SE, Enright H, Afdhal N, et al. Clot lysis by gastric juice: an in vitro study. Gut 1989;30:1704-7.
26. Huggins RM, Scates AC, Latour JK. Intravenous proton-pump inhibitors versus H2-antagonist for treatment of GI bleeding. Ann Phamacother 2003;37:433-7.
27. Lee K, Kye M, Jang JS, et al. Proteomic analysis revealed a strong association of a high level of α1-antitrypsin in gastric juice with gastric cancer. Proteomics 2004;4:3343-52.
28. Sudo I, Miyaoka M, Saito T. Significance of quantitative and qualitative analysis of fecal α1-antitrypsin in gastric cancer patients. Nippon Shokakibyo Gakkai Zasshi 1993;90:2873-81.
29. Reinhart WH, Weigand K, Kappeler M, et al. Comparison of gastrointestinal loss of α-1 antitrypsin and chromium-51-albumin in Menetrier's disease and the influence of ranitidine. Digestion 1983;26:192-6.
30. Takeda H, Nishise S, Furukawa M, et al. Fecal clearance of α1-antitrypsin with lansoprazole can detect protein-losing gastropathy Dig Dis Sci 1999;44:2313-8.
31. de la Fuente Perucho A, Millan J, Paya JM, et al. α1-Antitrypsin in the gastric and duodenal contents in ulcer patients - levels and correlations with the pH. Rev Esp Enferm Dig 1983;63:513-7.